Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

The Diagnosis Was ALK Positive NSCLC × ensartinib × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 19 Lung Neoplasms 4 Carcinoma 2 The Diagnosis Was ALK Positive NSCLC 1 Solid Tumor 1 Neoplasms 1 Brain Neoplasms 1 ALK-positive Advanced NSCLC 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05178511 2022-01-05

ERSGATR

Sun Yat-sen University

Phase 2 Unknown

The Diagnosis Was ALK Positive NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡